Objectives-In nonvalvular atrial fibrillation (NVAF) patients, the effect of left atrial appendage (LAA) morphology, structure, and hemodynamic characteristics evaluated by real-time 3D transesophageal echocardiography (RT3D-TEE) on thromboembolic risk has not been elucidated.
T hromboembolic events consist of the most feared complication of atrial fibrillation (AF) and remain a major cause of serious disability and death in these patients. Left atrial appendage (LAA) is the site of thrombus formation in 90% of patients with thrombosis as a result of nonvalvular AF (NVAF).
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The accurate estimation of thromboembolic risk and appropriate prevention are essential for NVAF patients.
Standard, life-long, oral vitamin K antagonists and novel oral anticoagulants for thromboembolic event prevention in NVAF patients are essential and may effectively improve prognosis. 4, 5 However, various adverse effects and intrinsic limitations exclude certain patients from this therapy. 6 Recently, transcatheter LAA closure has emerged as a new option for nonvalvular persistent AF patients with anticoagulation contraindications. 7, 8 However, the appropriate method for screening highrisk thrombosis AF patients, the selection of an appropriate thromboembolic event prevention method, and the maximization of treatment benefits remain controversial.
Real-time 3D transesophageal echocardiography (RT3D-TEE) may provide more accurate and novel views of the LAA compared with 2D transesophageal echocardiography (TEE), and has been demonstrated to feasibly and accurately measure LAA geometry. [9] [10] [11] This study was designed to determine the association between the LAA RT3D-TEE parameters and the incidence of NVAF-related thromboembolism, as well as the potential of these parameters to predict thromboembolism.
Materials and Methods
Study Subjects A total of 444 NVAF patients prepared for radiofrequency ablation between December 2012 and January 2015 in West China Hospital were enrolled in the study. An RT3D-TEE examination before radiofrequency ablation was conducted in all subjects to determine whether the LAA has thrombus. Patients with structural heart diseases, severe renal or hepatic dysfunction, history of radiofrequency ablation, and poor echocardiographic imaging quality were excluded. The CHA 2 DS 2 -VASc score (congestive heart failure [a history of clinical heart failure or left ventricular ejection fraction (LVEF) < 40%], hypertension, age 65-74 or 75 years, diabetes mellitus, previous stroke or transient ischemic attack (TIA), vascular disease [peripheral arterial disease, complex aortic plaque, or prior myocardial infarction] and female gender; each weighed by 1 except for stroke or TIA and age 75 years weighed by 2) was used to assess the thromboembolic risk. The baseline characteristics of this patient cohort are provided in Tables 1 and 2 . The study protocol was approved by the Ethics Committee of West China Hospital of Sichuan University (Sichuan, China). Written informed consent was obtained from all participants.
Echocardiography
Image acquisition was implemented by one highly qualified echocardiographer. Transthoracic echocardiography was conducted using an IE33 ultrasound system (Philips Medical Systems, Andover, MA) equipped with a S5-1 transducer (frequency 1-5 MHz). With a parasternal long-axis plane at end-diastole, the left atrium anteroposterior diameter was acquired, and the left ventricular ejection fraction was calculated using Teichholz's method. The peak transmitral flow velocities at the mitral tip during the early diastole (E wave) and the basal septal mitral annulus e' peak velocity by tissue Doppler were recorded using images acquired in the apical four-chamber view. The E/e' were subsequently calculated.
Transesophageal echocardiography was performed using the IE33 ultrasound system equipped with an X7-2t fully sampled 3D TEE transducer (frequency 2-7 MHz). A pulsed Doppler was used to obtain the LAA empting velocity with the sample point positioned at one-third depth from the LAA orifice. First, the gain settings were optimized using the narrow-angled acquisition mode, which enables RT3D-TEE imaging without the need for electrocardiographic gating and exhibits a narrow pyramidal volume. We subsequently used the 3D zoom mode, which displays a magnified pyramidal volume to visualize the LAA. Following assurance of adequate 3D visualization of the LAA, five consecutive cardiac cycle ultrasound images were stored and maintained a frame rate in the range of 12 to 20 frames/s. During image acquisition, 208 subjects were sinus rhythm and 236 subjects were AF rhythm.
Measurement of LAA Parameters
Images were digitally stored for offline analysis with QLAB 9.0 software (Philips Medical Systems, Andover, MA). By cropping the 3D echocardiographic imaging, we visualized the orifice of the LAA in the short axis. After visualizing the LAA ostium, standard measurements of the LAA orifice, area, and depth were obtained using a freehand tool of the 3DQ (Figure 1 ). The LAA boundary was defined similar to a previous report. 12 The GI-3DQ multiplanar reconstruction slice-plane mode of the QLAB software was used to calculate the LAA volumes and ejection fractions (EF-LAA) ( Figure 2 ) and reconstruct the LAA morphology. The EDV-LAA was defined as the largest volume, and the ESV-LAA was defined as the smallest volume. The EF-LAA was calculated as the percentage of (EDV-LAA-ESV-LAA)/ EDV-LAA. In patients with sinus rhythm, the EDV-LAA was measured at the onset of the ECG P-wave, and the ESV-LAA was measured at the onset of the ECG Rwave. For the patients in AF, the visually largest and smallest volumes were the EDV-LAA and ESV-LAA, respectively. For complex appendage shapes, we first guarantee adequate 3D visualization of the LAA and optimal image quality during image acquisition. Then in the measuring process, we increase the adjacent slices with no gap and repeatedly evaluate three times. The reconstructed LAAs were categorized into four different morphologies (cauliflower, chicken wing, cactus, and windsock) (Figure 3) , according to the previous study. 13 The measurements and classification were repeated by an independent sonographer in 60 randomly selected patients to determine the interobserver variability.
Statistical Analysis
All statistical analyses were conducted using SPSS version 17.0 (SPSS Inc, Chicago, IL). All continuous data are presented as the mean 6 standard deviation (SD) and were compared using independently sampled t tests or analyses of variance. Categorical variables are SBP, systolic blood pressure; DBP, diastolic blood pressure; HR, heart rate; LAi, left atrial diameter index; LVEF, left ventricular ejection fraction; CAD, coronary artery disease; CHF, congestive heart failure; COPD, chronic obstructive pulmonary disease; ACEI, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blocker. a P <.01, E/e' between 0 and 1 score subgroups. b P <.001, age between 0 and 1 score subgroups. c P <.01, E/e' between 0 and more than or equal to 2 score subgroups. d P <.001, age and LAi between 0 and more than or equal to 2 score subgroups. e P <.05, age between more than or equal to 2 and 1 score subgroups. f P <.01, LAi between more than or equal to 2 and 1 score subgroups. Note: Other variables were not significantly different among the three subgroups.
described as counts and percentages and were compared using Pearson's chi-square or Fisher exact tests.
Statistical significance was assumed at P less than .05. A logistic regression analysis was used to identify predictors of thromboembolic events in the NVAF patients. A receiver operator characteristic (ROC) curve was computed for the completed model, and a probability threshold was selected for the likelihood of predicting thromboembolic events based on the LAA volume. The resulting sensitivity and specificity were also estimated. The interobserver variability values were analyzed using Bland-Altman bias plots.
Results

Baseline Characteristics
This study consisted of 264 paroxysmal AF patients, 154 persistent AF patients, and 26 long-persistent AF patients, according to the 2011 American Heart Academy guidelines for AF. 14 The clinical and demographic characteristics among the different CHA 2 DS 2 -VASc thromboembolic risk subgroups are given in Table 1 . Most moderate and high CHA 2 DS 2 -VASc score subjects had standard anticoagulant therapy for international normalized ratio between 1.6 and 2.5, except for these with high bleeding risk and poor patient compliance. Twenty-eight patients in this study cohort had TEEindicated LAA thrombus, and half of them had a history of stroke or computed tomography (CT)/MRI-shown cerebral infarction. In general, the clinical and demographic characteristics were similar between the two subgroups (Table 2) .
NVAF Patients With LAA Thrombus Had a Deeper Depth and Larger End-Diastolic Volume
The orifice size (1.69 6 0.37, 1.76 6 0.35, and 1.91 6 0.36 cm), orifice area (2.63 6 0.91, 3.02 6 0.89, and ), and end-diastolic volume (5.09 6 2.34, 5.39 6 1.91, and 6.47 6 3.13 mL) of the LAA were increased with an increasing CHA 2 DS 2 -VASc risk score in the AF patients, whereas the emptying rate (0.54 6 0.21, 0.47 6 0.19, and 0.43 6 0.16 m/s) was decreased (Table 3) . Compared with the non-LAA thrombus patients, the event subgroup exhibited a deeper depth (2.85 6 0.57 versus 2.55 6 0.53 cm, P 5 .045), increased end-diastolic volume (7.39 6 3.47 versus 5.21 6 2.59 mL, P 5 .003), and was more prevalent in the cauliflower category (64.3 versus 25%, P 5 .004) ( Table 4) .
LAA Parameters Predict Thromboembolic Risk in NVAF Patients
A ROC curve was generated (Figure 4 ) to identify the LAA volume threshold associated with an increased risk of thromboembolic events. The inflection point in the ROC curve occurs at 8.6 mL, which suggests an increased risk of thromboembolic events with a volume greater than 8.6 mL. The ROC curve based on the LAA orifice had a poor predictive value (area under the curve was 0.605, 95% confidence interval [CI] 0.443-0.767, P 5 .188), and a predictive demarcation point could not be identified. In the multivariant logistic regression analysis that included all NVAF patients, the LAA enddiastolic volume (P 5 .002, odds ratio [OR] 1.556, 95% CI 1.176-2.057) and cauliflower (P 5 .001, OR 10.177, 95% CI 2.458-42.140) were independent predictors of thromboembolic events following adjustment for the CHA 2 DS 2 -VASc score (Table 5) .
Reproducibility
A Bland-Altman analysis of the measurements of the LAA orifice, area, depth, and volume between the two observers is shown in Figure 5 
Discussion
To date, LAA morphology and structure, assessed using CT and MRI, have been associated with thromboembolic risk; however, there is no widely accepted LAA parameter. Di Biase et al 13 reported that the morphologic appearance of the LAA was strongly associated with a history of TIA/stroke. Specifically, patients with a cauliflower LAA morphology were eight times more likely to have had an embolic event compared with patients with a chicken wing LAA morphology. Anselmino et al subsequently reported that LAA morphology was related to the burden of silent cerebral ischemia in , 90 and 135 , measurements were obtained from the top of the mitral valve annulus to a point 1 to 2 cm from the tip of the LSPV limbus. The depth of the LAA was defined as the longest straight line drawn from the midpoint of the ostium down the length of the primary lobe.The greatest values were used as the LAA orifice, area, and depth.
AF patients. 15 In addition to LAA morphology, a larger LAA orifice has been associated with stroke risk in patients with nonvalvular AF. 16 Furthermore, Khurram et al demonstrated converse conclusions, in which a smaller LAA orifice diameter was associated with prevalent stroke, and LAA morphologies were unassociated with stroke risk because of the substantial variability in LAA morphology identification among observers. 17 To date, the main imaging methods used to assess the LAA consist of CT, MRI, and ultrasonic and interventional radiology. 15, [18] [19] [20] The CT and interventional radiology examinations require radioactive radiation, and MRI has the intrinsic limitations of a lengthy imaging time and a contraindication for implanted metal devices. The RT3D-TEE method, which combines the advantages of TEE and RT3D echocardiography, is an accessible way to enable the improved assessment of intracardiac structures, including the LAA.
At present, the aim of the TEE examination before radiofrequency ablation in AF patients was to determine whether the LAA has thrombus, and the hemodynamic status of LAA is roughly reflected by the LAA emptying velocity. However, the LAA flow velocity calculation is usually an average of 9 times the measurement value in sinus patients, and an average of 10 to 20 times in patients with atrial fibrillation because of the variable structure during cardiac cycle. Therefore, the calculation process is complicated and the accuracy of the data is relatively poor. Our study confirmed that RT-3D TEE feasibly provides real-time 3D views of LAA and parameters. More importantly, we demonstrated that increased LAA volume and cauliflower category predict the thromboembolic risk of NVAF patients following adjustment for the CHA 2 DS 2 -VASc score. Because of the feasible provision of RT3D LAA views, and the predictability of LAA parameters for thromboembolic risk Figure 2 . Measurement of LAA volume. After the long-axis view of the LAA had been selected, a line was drawn from the LAA middle orifice to the apex to determine the LAA depth. Automatic generation of short-axis, multiplanar slices of the LAA from the orifice to the bottom, which are calculated using the GI3DQ plug-in, enables the calculation of the end-diastolic and end-systolic volumes using Simpson's method. The distance between the adjacent short-axis views may be adjusted, and the number of the slice would subsequently change. In our study, these slices are typically 1-to 3-mm thick with no gap. Tracing of the endocardial borders is then performed in the individual slices for subsequent calculation of the volume using automated software.
in NVAF patients, RT3D-TEE will have more advantages in the identification of high stroke-risk AF patients and play a key role in intraprocedural monitoring and guiding with the development of percutaneous LAA occlusion.
Interestingly, patients with an LAA volume greater than 8.6 mL demonstrated a significantly increased multivariable OR of thromboembolic events compared with the patients with an LAA volume less than or equal to 8.6 mL. The usefulness of imaging data not only depends on robust and reproducible measurements, but is also a guiding value for clinical treatment. As previously discussed, the LAA volumes in this study were measured using automated segmentation, and the ostium of the LAA was defined as 1 to 2 cm from the tip of the left superior pulmonary vein (LSPV) limbus. Compared with a recent study that used manual cursor tracing segmentation of MRI and the tip of the LSPV limbus for ostium, 21 the volumes reported here are smaller. The differentially defined boundary of the LAA is the main cause of the difference in volume measurements. Other factors that influence this difference include technical bias and the variable study crowd. Furthermore, the tip of the LSPV limbus is thin and soft; thus, 1 to 2 cm from the tip is more conducive to measurement location and LAA occlusion device fixation. Although RT3D-TEE might underestimate the LAA volume in complex appendage shapes for its relatively low spatial resolution, it provides unique visualization of the LAA in real time and quantitative analyzes LAA parameters feasibly. There may be additional benefit to combining these imaging methods in the evaluation of LAA size and morphology.
The CHADS 2 and CHA 2 DS 2 -VASc scores comprise the most commonly used scoring system for the evaluation of stroke risk. 22 However, because of different genetic backgrounds, the bleeding and thrombosis balance are not the same between Asian and western populations. Studies from Japan and Taiwan demonstrate that, compared with western populations, Asian populations have a relatively increased risk of bleeding and a relatively decreased risk of ischemic stroke. 23, 24 Therefore, schemes for stroke-prevention interventions may additionally benefit from a combination of the CHA 2 DS 2 -VASc and imaging data, such as the LAA volume and LAA type. For low to intermediate stroke-risk AF patients (CHA 2 DS 2 -VASc score 5 1), the LAA size and morphology may be considered when planning the anticoagulation management or antiplatelet therapy. If AF patients with an intermediate CHA 2 DS 2 -VASc score have a relatively increased LAA volume and complex LAA structure, anticoagulant treatment may be actively adopted, and LAA occlusion should be recommended for patients with contraindications to anticoagulation.
In conclusion, the current study suggested that the LAA depth and end-diastolic volume were increased in 
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